feed,title,long_url,short_url
BioRxiv,SARS-CoV-2 Virus like Particles produced by a single recombinant baculovirus generate potent neutralizing antibody that protects against variant challenge,https://biorxiv.org/cgi/content/short/2021.11.29.470349v1?rss=1,https://j.mp/3lj3ZZ5
BioRxiv,Heterologous Vaccination with SARS-CoV-2 Spike saRNA Prime followed by DNA Dual-Antigen Boost Induces Robust Antibody and T-Cell Immunogenicity against both Wild Type and Delta Spike as well as Nucleocapsid Antigens,https://biorxiv.org/cgi/content/short/2021.11.29.470440v1?rss=1,https://j.mp/31eLePe
BioRxiv,A human monoclonal antibody potently pan-neutralizes SARS-CoV-2 VOCs by targeting RBD invariant sites,https://biorxiv.org/cgi/content/short/2021.11.29.470356v1?rss=1,https://j.mp/3FWFKHU
BioRxiv,Peptide-antibody Fusions Engineered by Phage Display Exhibit Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants,https://biorxiv.org/cgi/content/short/2021.11.29.470362v1?rss=1,https://j.mp/3o7VGB2
BioRxiv,In silico study on the effects of disulfide bonds in ORF8 of SARS-CoV-2,https://biorxiv.org/cgi/content/short/2021.11.29.470346v1?rss=1,https://j.mp/3d3YCbJ
